We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$189M
Turnover
22.11%
1-Year Est. Return
67.72%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$32.1M
(-11%)
Cap. Flow
-$32.3M
Cap. Flow
% of AUM
-12.88%
Top 10 Holdings %
Top 10 Hldgs %
68.46%
Holding
112
New
6
Increased
15
Reduced
10
Closed
13
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DocGo
DCGO
|
+$3.77M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
+$1.73M |
| 3 |
VRNA
Verona Pharma
VRNA
|
+$1.28M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$803K |
| 5 |
Mereo BioPharma
MREO
|
+$667K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$16.8M |
| 2 |
Westrock Coffee
WEST
|
+$4.89M |
| 3 |
Panagram BBB-B CLO ETF
CLOZ
|
+$4.73M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$3.64M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.74% |
| 2 | Materials | 28.51% |
| 3 | Financials | 14.16% |
| 4 | Miscellaneous | 12.73% |
| 5 | Communication Services | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Kenvue
KVUE
$35.9B
| $41K | 0.02% |
2,235
| – | – |
2023 Q3
3 quarters
|
|
77
SouthState Bank Corp
SSB
$9.82B
| $41K | 0.02% |
534
| – | – |
2021 Q4
10 quarters
|
|
78
Chipotle Mexican Grill
CMG
$38.7B
| $31K | 0.01% |
500
| – | – |
2022 Q2
8 quarters
|
|
79
Linde
LIN
$227B
| $31K | 0.01% |
70
| – | – |
2022 Q2
8 quarters
|
|
80
DELISTED
Arch Resources, Inc.
ARCH
| $30K | 0.01% |
1,229
| – | – |
2022 Q2
8 quarters
|
|
81
UnitedHealth
UNH
$365B
| $29K | 0.01% |
57
| – | – |
2022 Q2
8 quarters
|
|
82
Home Depot
HD
$308B
| $28K | 0.01% |
80
| – | – |
2022 Q2
8 quarters
|
|
83
Blackstone
BX
$87.1B
| $26K | 0.01% |
210
| – | – |
2022 Q2
8 quarters
|
|
84
Thermo Fisher Scientific
TMO
$258B
| $25K | 0.01% |
45
| – | – |
2022 Q2
8 quarters
|
|
85
GE Aerospace
GE
$324B
| $24K | 0.01% |
150
-38
| -20% | -$6.07K |
2021 Q4
10 quarters
|
|
86
Valley National Bancorp
VLY
$7.05B
| $22K | 0.01% |
3,200
| – | – |
2021 Q4
10 quarters
|
|
87
Salesforce
CRM
$203B
| $20K | 0.01% |
77
| – | – |
2022 Q2
8 quarters
|
|
88
Adobe
ADBE
$97.9B
| $19K | 0.01% |
35
| – | – |
2022 Q2
8 quarters
|
|
89
Ovid Therapeutics
OVID
$441M
| $15K | 0.01% |
+20,000
| New | +$55.7K |
2024 Q2
0 quarters
|
|
90
Kyndryl
KD
$2.87B
| $11K | ﹤0.01% |
428
| – | – |
2023 Q1
5 quarters
|
|
91
The Kraft Heinz Company
KHC
$27.6B
| $11K | ﹤0.01% |
333
| – | – |
2021 Q4
10 quarters
|
|
92
Starwood Property Trust
STWD
$4.67B
| $8K | ﹤0.01% |
400
| – | – |
2021 Q4
10 quarters
|
|
93
GE Vernova
GEV
$247B
| $6K | ﹤0.01% |
+37
| New | +$5.86K |
2024 Q2
0 quarters
|
|
94
Chemours
CC
$1.94B
| $5K | ﹤0.01% |
240
| – | – |
2021 Q4
10 quarters
|
|
95
GE HealthCare
GEHC
$31.8B
| $4K | ﹤0.01% |
50
| – | – |
2023 Q4
2 quarters
|
|
96
Wabtec
WAB
$48.6B
| $1K | ﹤0.01% |
6
| – | – |
2021 Q4
10 quarters
|
|
97
Blackrock
BLK
$174B
| – | – |
-31
| Closed | -$26K | – |
|
98
Coherus Oncology
CHRS
$162M
| – | – |
-106,185
| Closed | -$254K | – |
|
99
Cenovus Energy
CVE
$59B
| – | – |
-95,000
| Closed | -$1.9M | – |
|
100
Cytokinetics
CYTK
$8.89B
| – | – |
-5,000
| Closed | -$351K | – |
|
Similar funds
SCA
FI
MFS
FRA
CAM
BAG
SHC
HC
David M. Knott Jr's Q2 2024 Portfolio in Review
As of Q2 2024, David M. Knott Jr held 112 positions worth $251M, down 11% from $283M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
David M. Knott Jr withdrew a net $32.3M in Q2 2024, closing 13 positions and reducing 10 holdings. Its most notable exit was FTAI Aviation, an estimated $16.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Materials and Financials.
Against the trend, David M. Knott Jr opened a new position in BioCryst Pharmaceuticals worth $1.94M.
- David M. Knott Jr's largest Q2 2024 buy was BioCryst Pharmaceuticals: 314,307 shares worth $1.94M.
- David M. Knott Jr added most to DocGo in Q2 2024, an estimated $3.77M increase.
- David M. Knott Jr's biggest Q2 2024 reduction was Panagram BBB-B CLO ETF, cutting an estimated $4.73M.
- David M. Knott Jr fully exited FTAI Aviation in Q2 2024, selling an estimated $16.8M.
- David M. Knott Jr's ten largest holdings make up 68% of its $251M portfolio in Q2 2024.
- David M. Knott Jr opened 6 new positions and closed 13 in Q2 2024.
- David M. Knott Jr's portfolio value fell 11% quarter-over-quarter to $251M.
Based on David M. Knott Jr's 13F filing for Q2 2024, filed 12 Aug 2024.